Nova Eye Medical Ltd (EYE.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -120 | -718 | -1,773 | -7,057 | -5,120 |
| Net Acquisitions | 97,347 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -97 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -679 | -520 | -379 | -354 | -181 |
| Other Investing Activity | -8,143 | -2,253 | -5,795 | -4,354 | -3,408 |
| Investing Cash Flow | $88,308 | $-3,491 | $-7,947 | $-11,765 | $-8,709 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 824 | 998 | 7,110 | 353 |
| Debt Repayment | -12,309 | -800 | -733 | -360 | -948 |
| Common Stock Issued | N/A | N/A | 23,577 | 10,290 | 4,732 |
| Common Stock Repurchased | N/A | N/A | -1,737 | N/A | N/A |
| Other Financing Activity | -980 | -133 | -143 | -575 | 1,902 |
| Financing Cash Flow | $-13,289 | $-109 | $21,962 | $16,465 | $6,039 |
| Exchange Rate Effect | 47 | -77 | 74 | -31 | 144 |
| Beginning Cash Position | 15,183 | 23,067 | 8,456 | 7,283 | 4,593 |
| End Cash Position | 95,649 | 15,183 | 23,067 | 8,456 | 7,283 |
| Net Cash Flow | $80,419 | $-7,807 | $14,537 | $1,204 | $2,546 |
| Free Cash Flow | |||||
| Capital Expenditure | -1,662 | -3,665 | -5,332 | -10,539 | -8,048 |
| Free Cash Flow | -1,662 | -3,665 | -5,332 | -10,539 | -8,048 |